Healthy Aging, Cognitive Impairment, and Dementia: Diagnosis, Care, Treatment, and Prevention

This symposium provides an overview of cognition and aging. Key concepts include cognitive impairment and dementia, the neuropsychological assessment, assessing capacity and decision-making abilities in the cognitively impaired and neuropsychiatric symptoms in neurodegenerative disease. Participants will learn about managing behaviors in patients with dementia as well as counseling and supporting the dementia family caregiver. Finally, participants will learn about mild cognitive impairment, the future of diagnosing dementia, new treatments, preventing dementing illness, and successful aging through positive lifestyle changes.

Lecture Format
Symposium - Lecture, slides, case illustrations, Q&A


Learn more about the lectures offered within this symposium here.


The last day to register for this symposium is Wednesday, October 2nd, 2013.

Course details

  • American Psychological Association (APA): 10.00
  • Event starts: Fri, Oct 04 2013 - 7:00 am
  • Event ends: Sat, Oct 05 2013 - 12:30 pm
  • Cost: $135.00

Target audience

PBHMind courses are designed for psychologists, social workers, therapists and other mental healthcare practitioners. 

Learning objectives

At the end of this continuing education symposium, participants will be able to:

  • Define dementia and describe the most common types
  • Describe the components of a thorough evaluation and diagnosis
  • Identify preventative measures for developing Alzheimer's disease
  • Explain the emotional, physical, social and economic impact of caring for a person with dementia within a family
  • Describe key evidence-based individual and group-based therapeutic and educational strategies in caring for a person with dementia
  • Describe the concept of delirium in lay terms
  • List simple meaures to prevent delirium
  • Discuss the management of delirium
  • Define resilience as it relates to Alzheimer's disease (AD)
  • Identify factors that contribute to resilient aging despite significant AD pathology
  • Discuss the cognitive reserve hypothesis and cognitive mechanisms underlying resilience
  • Describe the concept of aging society
  • Demonstrate techniques for preserving cognition in late life
  • Explain the modifiable and non-modifiable risk factors for developing a dementing illness
  • Identify the clinical questions that can be addressed by a neuropsychological assessment and which patients are likely to benefit from an assessment
  • Describe the assessment process and the typical tools used to evaluate a patient presenting with cognitive and/or behavioral change
  • Demonstrate ways to apply the evaluation impressions and recommendations to clinical practice


Smilow Center for Translational Research, Perelman School of Medicine at the University of Pennsylvania
3400 Civic Center Boulevard, Room 8-146AB
Philadelphia, PA 19104
United States

Faculty & credentials

Steven E. Arnold, MD
Professor of Psychiatry and Neurology
Director, Penn Memory Center and Clinical Core of the University of Pennsylvania Alzheimer's Disease Core Center
Director, Geriatric Psychiatry Section
Director, Cellular and Molecular Neuropathology Program
Associate Director, Institute on Aging
University of Pennsylvania

Dawn Mechanic-Hamilton, Ph.D.
Clinical Neuropsychologist
Penn Memory Center
Instructor, Department of Psychiatry, University of Pennsylvania

Nicholas Tsopelas, MD
Staff Psychiatrist, Penn Memory Center
Associate Director of Psychosomatic Medicine, Hospital of the University of Pennsylvania.
University of Pennsylvania Health System

Melissa Livney, Psy.D.
Clinical Psychologist
Section of Geriatric Psychiatry,
Perelman School of Medicine, University of Pennsylvania

Selam Negash, Ph.D., M.Sc.
Research Associate, Penn Memory Center
University of Pennsylvania Health System

Felicia Greenfield, LCSW
Associate Director for Clinical and Research Operations, Penn Memory Center
University of Pennsylvania Health System

Instructional Level 
Beginner to Advanced
Statement of Financial Relationships 

Steven E. Arnold, MD

  • National Institutes of Health, research support
  • BrightFocus Foundation, research support
  • National Philanthropic Trust, Marian S. Ware Alzheimer Program, research support
  • Merck, research support
  • Baxter, research support
  • Pfizer, research support
  • Johnson & Johnson, research support
  • Teva Pharmaceuticals, research support

Dawn Mechanic-Hamilton, Ph.D.
No commercial relationships to disclose
Melissa Livney, Psy.D.
No commercial relationships to disclose
Nicholas Tsopelas, MD
No commercial relationships to disclose
Selam Negash, Ph.D., M.Sc.
No commercial relationships to disclose
Felicia Greenfield, LCSW
No commercial relationships to disclose

This activity closed on November 1st, 2013 and is no longer available for enrollments.